Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
The Cancer Research Institute funds the full spectrum of discovery,
from lab to clinic to cure—making maximum impact on the future of cancer treatment.
Working in tandem with our growing network of researchers, supporters, patients, and ImmunoAdvocates, we're funding the best scientists doing the best research—all while promoting awareness, sharing up-to-date Immunotherapy information, and inspiring lifelong advocacy for the cause.
We support the science behind the treatment, funding lifesaving immunotherapy research and clinical trials around the world.
Apply for Grants & Fellowships
Meet Our Scientists
Your trusted resource for the latest credible, accurate cancer immunotherapy information for scientists, patients, and supporters.
Learn How Immunotherapy Works
See How Immunotherapy Impacts All Cancers
Join us in the cause to cure all cancers, advancing immunotherapy through events and awareness campaigns.
Create a Fundraising Team
Attend a CRI Event
Connecting you to an inspiring network of patients and advocates—that's a crucial part of our mission. See real stories of immunotherapy experiences, or share your own with others looking for insight and information.
Meet Your ImmunoCommunity
Find a Clinical Trial
We are the Cancer Research Institute, a powerful organization of research scientists and leadership staff dedicated to an important mission. Together, we work to develop immunotherapy as a cure for all cancers, connect a community of Immunoadvocates, and pave the way for a future free from cancer.
We're working for you—all of our supporters, patients, and scientists—to make the biggest impact possible in our efforts to cure cancer.
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Atezolizumab’s third approval in the last year provides an important treatment option for a neglected population of patients with bladder cancer
TIME magazine honors Dr. Allison’s development of the first checkpoint immunotherapy, which has led to a revolution in cancer treatment.